Welcome to our dedicated page for CME Group news (Ticker: CME), a resource for investors and traders seeking the latest updates and insights on CME Group stock.
CME Group Inc. operates a derivatives marketplace that supports trading and clearing in futures, options, cash and OTC markets. Its exchanges list benchmark products tied to interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals, with trading conducted through CME Globex, fixed income markets through BrokerTec, foreign exchange through EBS and central counterparty services through CME Clearing.
Company news commonly covers quarterly results, clearing and transaction fee revenue, market data revenue, dividends, new futures and options contracts, benchmark administration and regulatory approvals affecting clearing or margin services. Recurring updates also include cryptocurrency and equity index product expansion, U.S. repo and Term SOFR reference-rate activity, and the Purdue University/CME Group Ag Economy Barometer.
Summary not available.
CME Group announced a third-quarter dividend of $1.00 per share, set to be paid on September 27, 2022. Shareholders of record as of September 9, 2022 will be eligible for this dividend. As the leading derivatives marketplace, CME Group empowers clients to trade across various asset classes, offering a wide range of global benchmark products. This dividend declaration reflects the company's commitment to returning value to its shareholders, reinforcing confidence in its ongoing financial stability.
CME Group announced the expansion of its collateral policy to include Short-Term U.S. Treasury Exchange Traded Funds (ETFs) for initial margin requirements. This move enhances flexibility and efficiency for clearing members, allowing them to manage collateral costs more effectively. By accepting a wider range of collateral, CME Clearing aims to provide additional capital efficiencies. The initiative is expected to benefit market participants by simplifying the management of treasury portfolios and improving funding solutions. For more information, visit CME's official site.
The Purdue University/CME Group Ag Economy Barometer rose by 6 points in July to a reading of 103, indicating increased optimism among producers regarding current and future farm economic conditions. The Index of Current Conditions rose to 109, while the Index of Future Expectations reached 100. However, these indices remain 23-24% lower than last year. Producers expressed concerns about rising input prices (42%), lower crop prices (19%), and interest rates (17%). Despite some optimism, 49% expect their farms to be financially worse off next year.
CME Group reported a 20% growth in average daily volume (ADV) for July 2022, reaching 20.4 million contracts. The increase was driven by significant growth in Equity Index contracts, which saw a 40% rise, notably in micro and E-mini contracts. Additional highlights include record open interest for SOFR options and futures on July 29, with a total of 8.7 million and 7.3 million contracts, respectively. Other asset classes like Foreign Exchange and Interest Rate also experienced notable increases, enhancing CME Group's position in the derivatives market.
CME Group reported second-quarter 2022 financial results highlighting a revenue of $1.2 billion and an operating income of $750 million. Net income reached $663 million, with diluted EPS at $1.82. Adjusted net income was $717 million and diluted adjusted EPS at $1.97. The company reported a record average daily volume of 23.1 million contracts. Clearing and transaction fees generated $1.0 billion in revenue, while market data revenue was $152 million. CME returned $363 million in dividends during the quarter.
Summary not available.
CME Group reported a strong performance in Q2 2022, achieving an international average daily volume (ADV) of 6.3 million contracts, a 21% increase year-on-year. This growth was driven by significant rises in Equity Index products (43%), Interest Rate products (28%), Foreign Exchange products (24%), and Equity Options (44%). Globally, CME's ADV reached 23.1 million contracts, marking a 25% increase compared to Q2 2021.
CME Group's Chairman and CEO, Terry Duffy, expressed deep condolences on the passing of John O'Brien, Sr., a significant figure in the futures industry. O'Brien, a founding member of RJO & Associates, contributed greatly to the sector's global reach and fostered a family-oriented culture within the business. Duffy highlighted O'Brien's mentorship and leadership qualities, emphasizing the impact he made on many professionals in the industry. The statement reflects CME’s commitment to honoring its past leaders while continuing to empower market participants worldwide.
CME Group announced the launch of six new E-mini Sector futures contracts on August 8, 2022, pending regulatory approval. The new contracts aim to meet growing market demand for targeted sector exposure and include: E-mini S&P Regional Banks, Insurance, Biotechnology, Oil & Gas Exploration, Retail, and PHLX Semiconductor Sector Index futures. CME's existing Sector futures suite has seen a record 14% average daily volume increase in 2022, indicating strong market activity.